News Briefs - August 18, 2008



Parexel  International Corp. announced the successful closing of the acquisition of ClinPhone plc, a clinical technology organization. By combining ClinPhone with Perceptive Informatics, Parexel’s wholly-owned technology subsidiary, Perceptive is now one of the industry’s largest eClinical technology providers. As a result of the transaction, Perceptive Informatics’ eClinical technology offering now includes ClinPhone interactive voice and web response systems (IVRS/IWRS); Perceptive Medical Imaging; DataLabs, an electronic data capture (EDC) and clinical data management system; clinical trial management systems (CTMS); Impact enterprise CTMS solution; TrialWorks CTMS solution for small and mid-size companies, and electronic patient reported outcomes (ePRO). Read the press release.

OmniComm Systems Inc. introduced TrialMaster eLearning, a self-paced education tool. The on-demand training module joins a comprehensive suite of training options that are a part of OmniLearn for TrialMaster. OmniLearn users can take advantage of instructor-led live training, instructor-led web-based training, Train-the-Trainer sessions,customized training packages and now eLearning. One of the company’s largest clients, a major West Coast biotechnology company, is using the TrialMaster eLearning tool for 10 international studies at 427 sites worldwide.

Phase Forward has formed an alliance with AG Mednet, a clinical trials imaging network, to integrate Phase Forward’s InForm integrated trial management (ITM) system and AG Mednet’s imaging transport network. The integrated offering will enable clinical trial patient images to be tracked and managed from within the InForm ITM system. The joint solution will help streamline the process of transporting images between clinical sites and central reviewers, and will enable trial sponsors to access the status of patient images in real-time. Phase Forward also announced that it has extended its multi-year agreement with Eli Lilly and Company. Read the press releases.

Octagon Research Solutions announced that Summit Drug Development Services, LLC has chosen both its ViewPoint and StartingPoint to facilitate submission document authoring and integrated electronic regulatory submission management. Summit Drug Development Services accelerates the drug development process by providing high quality strategic focus and tactical implementation of preclinical, clinical, regulatory, and CMC services to the pharmaceutical and biotechnology industry. Read the press release.

Correction: The following brief in the July 28 issue linked to the wrong press release. This version links to website’s news page, where the July 16, 2008, press release can be found.

ProTrials Research Inc. announced that the Silicon Valley/San Jose Business Journal has chosen it as one of the area’s Top 50 Women-Owned Businesses for 2008. ProTrials is the only clinical research organization (CROs) to make the Silicon Valley/San Jose Business Journal top 50 and is one of only a handful of women-owned and operated CROs worldwide. It recently attained certification by the Women’s Business Enterprise National Council, an elite group of women-owned and operated businesses. Read the press release.

 

 

 

 

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1



White Papers & Special Reports

sgi - whp 1
Turning Genomics Data into Practical Insight
Sponsored by SGI

With worldwide sequencing capacity approaching 13 quadrillion DNA bases annually turning genomics data into knowledge is a true computational challenge. Read this paper and learn how the SGI UV coherent shared memory platform can:  

  • Speed results time while cost competitively tackling the most difficult computational problems across all omics disciplines. 
  • Push performance by scaling to extraordinary levels, up to 256 sockets (2,560 cores, 4,096 threads) per single system (one OS image). 

Provide support for up to 16TB of coherent shared memory in a single system image enabling extreme efficiency across a wide range of compute demands. 



accerlys-logo_2012_wh
New Complimentary Market Survey…
Collaborations and Communications Within Drug Discovery Research
Sponsored by Accelrys
This survey was conducted by the Cambridge Healthtech Media Group in January, 2012. It was sponsored by Accelrys related to their HEOS initiative to gather valid information around externalizing collaborative research while improving communications in the cloud. With 310 qualified industry respondents the survey findings reveal useful usage and trends patterns.  An insightful follow-on discussion and webinar related to this survey, and the HEOS by Scynexis SaaS portal is also available on the Bio-IT World website for complementary viewing.
 


Job Openings

tessella logo 
Scientific Software Engineer
Boston MA
$70,000 to $95,000
 

Tessella delivers software engineering and consulting services to leading pharmaceutical and biotech companies. We are recruiting Software Engineersto work with skilled bioinformaticians and scientists to identify business needs and recommend and develop technical solutions. Applicants require BS, MS or PhD in bioinformatics, biology or chemistry and 2+ years of software development in either: Java, C#, C++, C or VB.NET. 

Apply at http://jobs.tessella.com   

 

oxford nanopore logo 


 Early Access Collaborations Managers
Oxford Nanopore Technologies is developing a novel technology, GridIONTM for the direct, electronic analysis of DNA/RNA and other analytes.  As the system approaches the market, we are building a team of technically knowledgeable, highly motivated candidates with excellent customer service and facilitation skills to join our company as Collaboration Managers.  This is a unique opportunity to work with world-leading genomics customers throughout the early adoption phase of a new generation of DNA sequencing technology.. This is a facilitative, enabling role with responsibility for managing technology development collaborations with key customers at leading genomics institutions.  It will include long term management of the collaboration plan and milestones and associated meetings and documentation. Click here to find out more and apply   

Oxford Nanopore's GridION technology, VP, Sales and Marketing Oxford Nanopore Technologies is a fast-moving technology company that is developing a novel electronic molecular analysis technology. The technology is adaptable for the analysis of DNA/RNA, proteins, chemicals and other molecules.  It is therefore suitable for use in a variety of markets including scientific research and clinical applications.  As the technology approaches the market, Oxford Nanopore is seeking a visionary VP of sales and marketing to join the senior team.  The candidate will embrace the opportunities afforded by entering the market with a truly disruptive technology that has the potential to expand the number of users and the variety of applications in each target market.  This is a rare opportunity to influence the commercial strategy at an early phase of its commercial lifetime, in a well funded company.  Oxford Nanopore welcomes applications from candidates with a track record of high-level strategic commercial  leadership, who wish to apply a fresh approach to existing markets.  Experience in Life Sciences/DNA sequencing is central to this role, however we will consider your application if you have experience of disruptive technologies in other related industries.  We are particularly interested in candidates with strong expertise in the use of digital technologies for sales and marketing of scientific/technical products.  Click to  Apply  


 

For reprints and/or copyright permission, please contact  Tim McLucas, (781) 972-1342, tmclucas@healthtech.com .